Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael E Pyle"'
Autor:
Suzanne C Wetstein, Allison M Onken, Christina Luffman, Gabrielle M Baker, Michael E Pyle, Kevin H Kensler, Ying Liu, Bart Bakker, Ruud Vlutters, Marinus B van Leeuwen, Laura C Collins, Stuart J Schnitt, Josien P W Pluim, Rulla M Tamimi, Yujing J Heng, Mitko Veta
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231653 (2020)
Terminal duct lobular unit (TDLU) involution is the regression of milk-producing structures in the breast. Women with less TDLU involution are more likely to develop breast cancer. A major bottleneck in studying TDLU involution in large cohort studie
Externí odkaz:
https://doaj.org/article/9f205b7ac43a42f2bdc816d3256b1561
Autor:
Katherine Tian, Christopher A Rubadue, Douglas I Lin, Mitko Veta, Michael E Pyle, Humayun Irshad, Yujing J Heng
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222641 (2019)
We developed an automated 2-tiered Fuhrman's grading system for clear cell renal cell carcinoma (ccRCC). Whole slide images (WSI) and clinical data were retrieved for 395 The Cancer Genome Atlas (TCGA) ccRCC cases. Pathologist 1 reviewed and selected
Externí odkaz:
https://doaj.org/article/de403329d548411181fbb3158d08342b
Autor:
Jordana Phillips, Valerie Fein-Zachary, Gabrielle M. Baker, Gerburg M. Wulf, Michael E. Pyle, Yujing J. Heng, Richard A. Bartlett, Adam M. Tobias
Publikováno v:
Transgender Health
Transgender Health, Vol 4, Iss 1, Pp 326-330 (2019)
Transgender Health, Vol 4, Iss 1, Pp 326-330 (2019)
Purpose: To characterize a cohort of transgender men and masculine-centered gender nonconforming individuals who underwent gender-affirming chest-contouring surgeries at our institution between 2013 and 2018. Methods: Demographics, medical history, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289df1a655693ae57d55a23d00c426c0
http://europepmc.org/articles/PMC6863056
http://europepmc.org/articles/PMC6863056
Autor:
Christina Luffman, Yujing J. Heng, Ying Liu, Michael E. Pyle, Gabrielle M. Baker, Josien P. W. Pluim, Laura C. Collins, Allison Onken, Stuart J. Schnitt, Mitko Veta, Kevin H. Kensler, Rulla M. Tamimi, Suzanne C. Wetstein
Publikováno v:
Archives of Pathology & Laboratory Medicine. 143:e2-e226
and case study poster sessions will be conducted during the 2019 College of American Pathologists Annual Meeting (CAP19), which is scheduled for September 21 to 25, 2019. The meeting will take place at the Gaylord Palms Resort & Convention Center, Ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::095f19f969251a6c613882fa3e5bcc0b
https://doi.org/10.5858/arpa.2019-0901-ab
https://doi.org/10.5858/arpa.2019-0901-ab
Autor:
Rulla M. Tamimi, Christina Luffman, Suzanne C. Wetstein, Kevin H. Kensler, Marinus Bastiaan Van Leeuwen, Gabrielle M. Baker, Allison M. Onken, Laura C. Collins, Ruud Vlutters, Ying Liu, Stuart J. Schnitt, Josien P. W. Pluim, Michael E. Pyle, Bart Bakker, Mitko Veta, Yujing J. Heng
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231653 (2020)
PLoS ONE, 15(4):e0231653. Public Library of Science
PLoS ONE
PLoS ONE, 15(4):e0231653. Public Library of Science
PLoS ONE
Terminal duct lobular unit (TDLU) involution is the regression of milk-producing structures in the breast. Women with less TDLU involution are more likely to develop breast cancer. A major bottleneck in studying TDLU involution in large cohort studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5349429d6c0991aebd45bd5cb862a2c0
https://doaj.org/article/9f205b7ac43a42f2bdc816d3256b1561
https://doaj.org/article/9f205b7ac43a42f2bdc816d3256b1561
Autor:
Yujing J. Heng, Katherine Tian, Humayun Irshad, Michael E. Pyle, Douglas I. Lin, Christopher A. Rubadue, Mitko Veta
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222641 (2019)
PLoS ONE, 14(10):e0222641. Public Library of Science
PLoS ONE
PLoS ONE, 14(10):e0222641. Public Library of Science
PLoS ONE
We developed an automated 2-tiered Fuhrman’s grading system for clear cell renal cell carcinoma (ccRCC). Whole slide images (WSI) and clinical data were retrieved for 395 The Cancer Genome Atlas (TCGA) ccRCC cases. Pathologist 1 reviewed and select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54cf318f4d94c47e2af7b86626bd0dc4
Autor:
Yujing J. Heng, Gabrielle M. Baker, Roswitha Kammler, Giuseppe Viale, Meredith M. Regan, Michael E. Pyle, Aditi Hazra, Marco Colleoni, Myles Brown, Beat Thürlimann, Kevin H. Kensler, Stuart J. Schnitt, Rulla M. Tamimi
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background The androgen receptor (AR) is an emerging prognostic marker and therapeutic target in breast cancer. AR is expressed in 60–80% of breast cancers, with higher prevalence among estrogen receptor-positive (ER+) tumors. Androgen treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db9f484f4c79a8e71547ee0036dc95e
https://doi.org/10.1186/s13058-019-1118-z
https://doi.org/10.1186/s13058-019-1118-z
Autor:
Kevin H. Kensler, V N Sankar, Rulla M. Tamimi, Gabrielle M. Baker, Jianghua Wang, Andreea Lucia Stancu, Christopher A. Rubadue, Yujing J. Heng, Laura C. Collins, Joel S. Parker, Katherine A. Hoadley, A H Eliassen, Susan E. Hankinson, David J. Hunter, Michael E. Pyle, Xuehong Zhang
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 28(4)
Background: Modified median and subgroup-specific gene centering are two essential preprocessing methods to assign breast cancer molecular subtypes by PAM50. We evaluated the PAM50 subtypes derived from both methods in a subset of Nurses' Health Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a5c32cf561021395cd3edcb48224ac
https://pubmed.ncbi.nlm.nih.gov/30591591
https://pubmed.ncbi.nlm.nih.gov/30591591
Autor:
Beat Thürlimann, Yujing J. Heng, Marco Colleoni, Kevin H. Kensler, Michael E. Pyle, Myles Brown, Stuart J. Schnitt, Meredith M. Regan, Rulla M. Tamimi, Giuseppe Viale
Publikováno v:
Cancer Research. 78:4207-4207
Background The androgen receptor (AR) is emerging as a potential biomarker of breast cancer prognosis and therapeutic target. AR is expressed in 60-80% of breast cancers, with higher prevalence among estrogen receptor (ER) positive tumors. Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::597344163bfa2a594cbf31f41964260a
https://doi.org/10.1158/1538-7445.am2018-4207
https://doi.org/10.1158/1538-7445.am2018-4207
Autor:
Kevin H. Kensler, Meredith M. Regan, Yujing J. Heng, Gabrielle M. Baker, Michael E. Pyle, Stuart J. Schnitt, Aditi Hazra, Roswitha Kammler, Beat Thürlimann, Marco Colleoni, Giuseppe Viale, Myles Brown, Rulla M. Tamimi
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Background The androgen receptor (AR) is an emerging prognostic marker and therapeutic target in breast cancer. AR is expressed in 60–80% of breast cancers, with higher prevalence among estrogen receptor-positive (ER+) tumors. Androgen tre
Externí odkaz:
https://doaj.org/article/7ef146cc6971484fbc4ebd6c88f2c0e4